A large retrospective cohort study revealed that T2DM patients treated with GLP-1RAs exhibited a significantly reduced risk of developing dementia compared with those receiving other glucose-lowering therapies.126 In a clinical trial involving cognitively intact individuals aged 4570 years at risk for AD, liraglutide administration for 12 weeks enhanced intrinsic connectivity within the default mode network as measured by resting-state functional magnetic resonance imaging, although no significant cognitive improvements were observed during the study period.127 In patients with mild cognitive impairment and AD, an 18-month course of exenatide was well tolerated but did not yield significant changes in clinical or cognitive outcomes or in most neuroimaging or biomarker assessments, except for a reduction in plasma neuronal extracellular vesicle A42 levels, potentially reflecting systemic neuronal status
Rangaswami J, Bhalla V, de Boer IH, et al
When compared with Naltrexone/Bupropion, Tirzepatide users show lower rates of cataracts (HR 0.46, 95% CI 0.230.92, p = 0.025) and oculomotor dysfunction (HR 0.31, 95% CI 0.160.60, p = 2.3 10 4 )
Start your intake How Semaglutide Affects Kidney Function Semaglutide does not directly damage the kidneys, but it may indirectly influence kidney function through metabolic changes
A prpria reviso de 2026 destaca a ausncia de dados humanos robustos para essas molculas
Missing seal damage during storage results in moisture and oxygen exposure
